Clinical Trials Directory

Trials / Completed

CompletedNCT02218203

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination (Factorial Design) Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This randomized, placebo-controlled, double-blind 4x4 crossover clinical trial was part of a larger NIH-funded study to evaluate the analgesic efficacy of multiple dose-combinations of chronic oral (PO) dextromethorphan and intravenous (IV) lidocaine in central neuropathic pain following spinal cord injury.

Detailed description

This trial has several objectives: Primary Objective To determine which combination (dose-ratio) of dextromethorphan and lidocaine provides the best balance of pain reduction and toxicity. Secondary Objectives include To evaluate the analgesic efficacy of both dextromethorphan and lidocaine in attenuating pain related to central nervous system sensitization, specifically spontaneous pain, mechanical allodynia, and hyperalgesia.

Conditions

Interventions

TypeNameDescription
DRUGDextromethorphanAdministered in 4 periods (placebo, low dose, medium dose, and high dose) for each subject, relative to each subject's MTD)
DRUGLidocaine0mg, 1mg, 2mg, and 4mg Lidocaine per kg of lean body mass (LBM), during each of the 4 dextromethorphan periods (placebo, low dose, medium dose, and high dose)
DRUGPlacebo (Dextromethorphan)0mg Dextromethorphan
DRUGPlacebo (Lidocaine)0mg/kg LBM Lidocaine

Timeline

Start date
2003-04-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2014-08-18
Last updated
2025-12-08
Results posted
2018-03-22

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02218203. Inclusion in this directory is not an endorsement.